Affinity Investment Advisors LLC Has $376,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Affinity Investment Advisors LLC cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 51.7% in the 4th quarter, HoldingsChannel reports. The fund owned 14,387 shares of the pharmacy operator’s stock after selling 15,373 shares during the quarter. Affinity Investment Advisors LLC’s holdings in Walgreens Boots Alliance were worth $376,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC raised its position in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares in the last quarter. Highlander Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Venturi Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 981 shares in the last quarter. Rocky Mountain Advisers LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. Finally, Quest Partners LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

NASDAQ WBA traded down $0.21 on Wednesday, hitting $16.47. The stock had a trading volume of 8,107,964 shares, compared to its average volume of 13,065,792. Walgreens Boots Alliance, Inc. has a 52-week low of $16.31 and a 52-week high of $32.89. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The company has a market capitalization of $14.21 billion, a price-to-earnings ratio of -2.38, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80. The firm has a 50-day moving average of $18.75 and a 200-day moving average of $21.27.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter last year, the company posted $1.16 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. Equities analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 6.07%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Analysts Set New Price Targets

WBA has been the topic of a number of recent analyst reports. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. SVB Leerink decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research note on Monday, March 18th. Truist Financial reissued a “hold” rating and issued a $25.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. UBS Group reduced their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Finally, Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $24.36.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction on Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.